BRIEF-Acrivon Therapeutics, Inc Q1 Income From Operations USD -19.902 Million

Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc.

ACRV

0.00

May 13 (Reuters) - Acrivon Therapeutics, Inc Q1 operating expenses USD 19.902 million.

  • Q1 basic EPS USD -0.49
  • Q1 net income USD -19.042 million